Scott Adams, the brilliant mind behind the iconic Dilbert comic strip, announced on YouTube over the weekend that he's paralyzed from the waist down while grappling with aggressive prostate cancer.
For those unfamiliar, Adams, 68, has been fighting this brutal disease since at least March 2025, revealing a dire situation that’s left him bedridden and pleading for urgent help.
American retirees, who’ve chuckled at Dilbert’s office satire for decades, now face the sobering reality of a cultural icon in crisis, with potential medical delays raising questions about healthcare access—a system many fear is bogged down by bureaucracy at a steep human cost.
Adams, whose Dilbert has skewered corporate nonsense since 1989 across 57 countries in 19 languages, first confirmed his prostate cancer diagnosis earlier this year, though he hinted he’d been battling it longer than some politicians admit their own health woes.
Initially keeping his struggle private, he shocked fans with a bedside announcement on YouTube, admitting, “Paralyzed below the waist,” and clarifying he can feel but not move.
That’s a gut punch for a man whose wit has sold over 20 million books and calendars, and it’s hard not to wonder if a system prioritizing paperwork over patients is partly to blame for his decline.
Adams is undergoing radiation, hoping it halts tumor growth and restores some strength to his lower body, but he’s pinning bigger hopes on Pluvicto, a new FDA-approved drug he believes could extend his life.
Yet, frustration mounts as he claims Kaiser of Northern California has stalled scheduling his Pluvicto infusion, leaving him to publicly lament, “I am declining fast.”
Conservative taxpayers can’t help but grimace—when even a near-$70 million net worth can’t cut through healthcare red tape, what chance do regular folks have against such institutional inertia?
Desperate, Adams took to social media in November 2025, begging President Donald Trump to intervene and get Kaiser to schedule his treatment pronto.
Trump, never one to shy away from a fight against bloated systems, fired back on Truth Social with a swift “On it!” showing the kind of decisive action many on the right crave.
A follow-up from a presumed associate named Kennedy asking how to reach Adams suggests the plea didn’t fall on deaf ears, a rare win for those skeptical of elite indifference.
By December 2025, during a livestream, Adams noted his social media outcry on platform X might’ve nudged Kaiser to pay more attention, though he’s quick to question if that’s fair to other patients.
Still, his second Pluvicto dose remains postponed due to ongoing radiation, a setback for a man who was told he might not survive past summer 2025.
While Adams’ controversial conservative stances—like a 2023 rant costing him a book deal with Penguin Random House and 77 newspapers dropping Dilbert over anti-woke plots—have made enemies, no one can deny the man’s fight for life deserves respect over petty culture war grudges.
